Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gauthier-Villars

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Eye (London, England)|September 17, 2011
Familial retinoblastoma: fundus screening schedule impact and guideline proposal. A retrospective studyP-R Rothschild, D Lévy, A Savignoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2000
Familial invasive breast cancers: worse outcome related to BRCA1 mutationsD Stoppa-Lyonnet, Y Ansquer, H Dreyfus, et al.
Human Mutation|January 15, 2004
Comprehensive screening for constitutional RB1 mutations by DHPLC and QMPSFC Houdayer, M Gauthier-Villars, A Laugé, et al.
Familial Cancer|September 16, 2010
Contribution of CDKN2A/P16 ( INK4A ), P14 (ARF), CDK4 and BRCA1/2 germline mutations in individuals with suspected genetic predisposition to uveal melanomaB Buecher, M Gauthier-Villars, L Desjardins, et al.
British Journal of Cancer|March 7, 2013
Short-term psychological impact of the BRCA1/2 test result in women with breast cancer according to their perceived probability of genetic predisposition to cancerA Brédart, J L Kop, A Depauw, et al.
Journal Francais D'Ophtalmologie|May 16, 2015
Treatment of retinoblastoma: The Institut Curie experience on a series of 730 patients (1995 to 2009)L Lumbroso-Le Rouic, A Savignoni, C Levy-Gabriel, et al.
Familial Cancer|February 22, 2012
French women's breast self-examination practices with time after undergoing BRCA1/2 genetic testingC Maheu, T Apostolidis, A Petri-Cal, et al.
Pediatric Blood & Cancer|August 24, 2013
Malformations, genetic abnormalities, and Wilms tumorS Dumoucel, M Gauthier-Villars, D Stoppa-Lyonnet, et al.
Oncogene|June 2, 2015
Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutationsL Golmard, C Delnatte, A Laugé, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Eye (London, England)|September 17, 2011
Familial retinoblastoma: fundus screening schedule impact and guideline proposal. A retrospective studyP-R Rothschild, D Lévy, A Savignoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2000
Familial invasive breast cancers: worse outcome related to BRCA1 mutationsD Stoppa-Lyonnet, Y Ansquer, H Dreyfus, et al.
Human Mutation|January 15, 2004
Comprehensive screening for constitutional RB1 mutations by DHPLC and QMPSFC Houdayer, M Gauthier-Villars, A Laugé, et al.
Familial Cancer|September 16, 2010
Contribution of CDKN2A/P16 ( INK4A ), P14 (ARF), CDK4 and BRCA1/2 germline mutations in individuals with suspected genetic predisposition to uveal melanomaB Buecher, M Gauthier-Villars, L Desjardins, et al.
British Journal of Cancer|March 7, 2013
Short-term psychological impact of the BRCA1/2 test result in women with breast cancer according to their perceived probability of genetic predisposition to cancerA Brédart, J L Kop, A Depauw, et al.
Journal Francais D'Ophtalmologie|May 16, 2015
Treatment of retinoblastoma: The Institut Curie experience on a series of 730 patients (1995 to 2009)L Lumbroso-Le Rouic, A Savignoni, C Levy-Gabriel, et al.
Familial Cancer|February 22, 2012
French women's breast self-examination practices with time after undergoing BRCA1/2 genetic testingC Maheu, T Apostolidis, A Petri-Cal, et al.
Pediatric Blood & Cancer|August 24, 2013
Malformations, genetic abnormalities, and Wilms tumorS Dumoucel, M Gauthier-Villars, D Stoppa-Lyonnet, et al.
Oncogene|June 2, 2015
Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutationsL Golmard, C Delnatte, A Laugé, et al.
Pageof 2